Sort
23,748 grants matching “melanoma”
Cachexia-mediated FcRn Modulation and Its Impact on Anti-PD1 Therapy in Lung Cancer
$615,393Mitch A Phelps · Ohio State University · R01 · FY2023 · CA
Dissecting neoepitope-specific clonal T cell populations in advanced melanoma patients vaccinated with personal neoantigen peptides partnered with local and systemic immune checkpoint Inhibition
$615,390Patrick Alexander Ott · Dana-Farber Cancer Inst · R01 · FY2023 · CA
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$615,182Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Processed Antigen Characterization by Mass Spectrometry
$615,162Donald F Hunt · University Of Virginia · R01 · FY2017 · AI
Sustainability of the Go Sun Smart Program in a Recreation Industry
$615,123Barbara Walkosz · Klein Buendel, Inc. · R01 · FY2011 · CA
Regulatory T cells in cancer therapy
$614,963Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Small-molecule degraders of STAT5
$614,944Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Transcriptional Reprogramming in Melanoma Plasticity
$614,911Chengyu Liang · Wistar Institute · R01 · FY2024 · CA
Genotyping for epidemiology studies
$614,909Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas
$614,852Duane A. Mitchell · University Of Florida · R01 · FY2019 · CA
Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy
$614,801Vinod P Balachandran · Sloan-Kettering Inst Can Research · U01 · FY2021 · CA
Targeting BPTF in the Therapy of BRAF-mutant Melanoma
$614,787Mohammed Kashani-Sabet · California Pacific Med Ctr Res Institute · R01 · FY2017 · CA
O-Glycosylation of Epidermal Growth Factor-like Modules
$614,671Robert S. Haltiwanger · State University New York Stony Brook · R01 · FY2011 · GM
Mechanical regulation of the microenvironmental niche in skin tumorigenesis
$614,647Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
A Human Intraepithelial Tumor Microenvironment Assay
$614,540Barbara Lynn Allen-Hoffmann · Stratatech Corporation · R42 · FY2010 · CA
Dissecting the role of hypoxia in T cell differentiation in cancer
$614,462Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Dissecting the role of hypoxia in T cell differentiation in cancer
$614,462Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Basic applications for total-body PET in oncology
$614,406Lorenzo Nardo · University Of California At Davis · R01 · FY2021 · CA
A Registry-Based Study of Patterns of Use of Targeted Therapies for Metastatic Cancers in Diverse Populations
$614,203Christine Veenstra · University Of Michigan At Ann Arbor · R37 · FY2024 · CA
The Framingham School Nevus Study
$613,962Sloan-Kettering Institute For Cancer Res · R01 · FY2004 · AR
Adoptive T Cell Therapy for Pancreatic Cancer
$613,867Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
ITIM-receptors for cancer treatment
$613,805Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2020 · CA
TARGETING ANGIOGENESIS WITH TOXIN-VEGF FUSION PROTEINS
$613,618Sibtech, Inc. · R44 · FY2002 · CA
(PQD1) Evolution of vemurafenib resistance in circulating melanoma cells
$613,546Carl D Novina · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies
$613,358Jin Wang · Baylor College Of Medicine · R01 · FY2024 · CA